A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia - PubMed (original) (raw)
Meta-Analysis
A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia
Lene Vase et al. Pain. 2002 Oct.
Abstract
A previous meta-analysis of clinical analgesic trial studies showed generally low magnitudes of placebo analgesia (N. Engl. J. Med. 344 (2001) 1594). However, as studies included in their analysis used only placebo as a control condition, we conducted two meta-analyses, one in which 23 studies used only placebo as a control condition, and one in which 14 studies investigated placebo analgesic mechanisms. Magnitudes of placebo analgesic effects were much higher in the latter (mean effect size=0.95) as compared to the former (mean effect size=0.15) and were significantly different (P=0.003). This difference as well as differences in effect sizes within studies of placebo mechanisms may be parsimoniously explained by differences in expected pain levels produced by placebo suggestions and by conditioning. Furthermore, some of the studies of placebo analgesic mechanisms indicate that the magnitude of placebo analgesia is higher when the placebo analgesic effect is induced via suggestion combined with conditioning than via suggestion alone or conditioning alone. Based on these findings, we suggest that placebo analgesic effects are most optimally conceptualized in terms of perception of the placebo agent, and therefore a new definition of placebo response is proposed.
Comment in
- Unreliable analysis of placebo analgesia in trials of placebo pain mechanisms.
Hróbjartsson A, Gøtzsche PC. Hróbjartsson A, et al. Pain. 2003 Aug;104(3):714-715. doi: 10.1016/S0304-3959(03)00164-7. Pain. 2003. PMID: 12927646 No abstract available.
Similar articles
- Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007.
Vase L, Petersen GL, Riley JL 3rd, Price DD. Vase L, et al. Pain. 2009 Sep;145(1-2):36-44. doi: 10.1016/j.pain.2009.04.008. Epub 2009 Jun 25. Pain. 2009. PMID: 19559529 - Partial reinforcement, extinction, and placebo analgesia.
Au Yeung ST, Colagiuri B, Lovibond PF, Colloca L. Au Yeung ST, et al. Pain. 2014 Jun;155(6):1110-1117. doi: 10.1016/j.pain.2014.02.022. Epub 2014 Mar 3. Pain. 2014. PMID: 24602997 Free PMC article. Clinical Trial. - Enhancing placebo analgesia: Unravelling the powerful interplay of ownership and verbal suggestion.
Yeung VWL. Yeung VWL. Eur J Pain. 2024 Nov;28(10):1701-1718. doi: 10.1002/ejp.2303. Epub 2024 Jun 24. Eur J Pain. 2024. PMID: 38923640 Clinical Trial. - Placebo analgesia: friend or foe?
Price DD, Fillingim RB, Robinson ME. Price DD, et al. Curr Rheumatol Rep. 2006 Dec;8(6):418-24. doi: 10.1007/s11926-006-0035-1. Curr Rheumatol Rep. 2006. PMID: 17092440 Review. - [Placebo analgesia and sleep].
Chouchou F, Lavigne GJ. Chouchou F, et al. Pathol Biol (Paris). 2014 Oct;62(5):270-5. doi: 10.1016/j.patbio.2014.07.001. Epub 2014 Aug 10. Pathol Biol (Paris). 2014. PMID: 25113307 Review. French.
Cited by
- Differential neural activity predicts the long-term stability of the effects of positive and negative expectations on pain.
Wolf MI, Wittkamp CA, Rose M. Wolf MI, et al. Sci Rep. 2024 Nov 13;14(1):27874. doi: 10.1038/s41598-024-77693-z. Sci Rep. 2024. PMID: 39537677 Free PMC article. - Placebo effects beyond dopamine.
Jensen KB. Jensen KB. PLoS Biol. 2024 Sep 25;22(9):e3002812. doi: 10.1371/journal.pbio.3002812. eCollection 2024 Sep. PLoS Biol. 2024. PMID: 39321143 Free PMC article. - Dopamine has no direct causal role in the formation of treatment expectations and placebo analgesia in humans.
Kunkel A, Asan L, Krüger I, Erfurt C, Ruhnau L, Caliskan EB, Hackert J, Wiech K, Schmidt K, Bingel U. Kunkel A, et al. PLoS Biol. 2024 Sep 24;22(9):e3002772. doi: 10.1371/journal.pbio.3002772. eCollection 2024 Sep. PLoS Biol. 2024. PMID: 39316644 Free PMC article. Clinical Trial. - Placebo effects in randomized trials of pharmacological and neurostimulation interventions for mental disorders: An umbrella review.
Huneke NTM, Amin J, Baldwin DS, Bellato A, Brandt V, Chamberlain SR, Correll CU, Eudave L, Garner M, Gosling CJ, Hill CM, Hou R, Howes OD, Ioannidis K, Köhler-Forsberg O, Marzulli L, Reed C, Sinclair JMA, Singh S, Solmi M, Cortese S. Huneke NTM, et al. Mol Psychiatry. 2024 Jun 24. doi: 10.1038/s41380-024-02638-x. Online ahead of print. Mol Psychiatry. 2024. PMID: 38914807 - Learning by observing: a systematic exploration of modulatory factors and the impact of observationally induced placebo and nocebo effects on treatment outcomes.
Klauß H, Kunkel A, Müßgens D, Haaker J, Bingel U. Klauß H, et al. Front Psychol. 2024 Apr 18;15:1293975. doi: 10.3389/fpsyg.2024.1293975. eCollection 2024. Front Psychol. 2024. PMID: 38699574 Free PMC article.
References
- Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci. 1999;19:484-494.
- Amanzio M, Pollo A, Maggi G, Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001;90:205-215.
- Beecher HK. The powerful placebo. J Am Med Assoc. 1955;159:1602-1606.
- Beecher HK. Increased stress and effectiveness of placebos and active' drugs. Science. 1960;132:91-92.
- Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist prolumide on placebo analgesia. Pain. 1996;64:535-543.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical